{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T02:15:08Z","timestamp":1775787308646,"version":"3.50.1"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,26]],"date-time":"2015-08-26T00:00:00Z","timestamp":1440547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0133798","type":"journal-article","created":{"date-parts":[[2015,8,26]],"date-time":"2015-08-26T18:18:40Z","timestamp":1440613120000},"page":"e0133798","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effect of Silodosin, an Alpha1A-Adrenoceptor Antagonist, on Ventral Prostatic Hyperplasia in the Spontaneously Hypertensive Rat"],"prefix":"10.1371","volume":"10","author":[{"given":"Shogo","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiota","family":"Tsounapi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youichirou","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darryl T.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoaki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,8,26]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJMcp1106637","article-title":"Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms","volume":"367","author":"AV Sarma","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3810\/psm.2009.12.1752","article-title":"Benign prostatic hyperplasia: does lifestyle play a role?","volume":"37","author":"RJ Barnard","year":"2009","journal-title":"Phys Sportsmed"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2011.03.055","article-title":"The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation","volume":"60","author":"C De Nunzio","year":"2011","journal-title":"Eur Urol"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bju.12728","article-title":"Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis","volume":"115","author":"M Gacci","year":"2015","journal-title":"BJU Int"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.urology.2013.03.087","article-title":"Beneficial influence of carvedilol on urologic indices in patients with hypertension and benign prostatic hyperplasia: results of a randomized, crossover study","volume":"82","author":"J Lewandowski","year":"2013","journal-title":"Urology"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/HJH.0000000000000119","article-title":"Doxazosin to treat hypertension: it\u2019s time to take it personally\u2014a retrospective analysis of 19, 495 patients","volume":"32","author":"T Wolak","year":"2014","journal-title":"J Hypertens"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2011.11.013","article-title":"The correlation between metabolic syndrome and prostatic diseases","volume":"61","author":"C De Nunzio","year":"2012","journal-title":"Eur Urol"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/bju.12118","article-title":"The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH)","volume":"112","author":"G Gandaglia","year":"2013","journal-title":"BJU Int"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jep.2014.09.025","article-title":"Abacopteris penangiana exerts testosterone-induced benign prostatic hyperplasia protective effect through regulating inflammatory responses, reducing oxidative stress and anti-proliferative","volume":"157","author":"X Yang","year":"2014","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.urology.2007.11.155","article-title":"Longitudinal association between prostatitis and development of benign prostatic hyperplasia","volume":"71","author":"JL Sauver","year":"2008","journal-title":"Urology"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1046\/j.1464-410x.1999.00352.x","article-title":"Asymptomatic inflammation and\/or infection in benign prostatic hyperplasia","volume":"84","author":"JC Nickel","year":"1999","journal-title":"BJU Int"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/j.1939-4640.2000.tb03276.x","article-title":"Spontaneous hyperplasia of the ventral lobe of the prostate in aging genetically hypertensive rats","volume":"21","author":"E Golomb","year":"2000","journal-title":"J Androl"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0090-4295(02)02167-2","article-title":"Determination of percent area density of epithelial and stromal components in development of prostatic hyperplasia in spontaneously hypertensive rats","volume":"61","author":"M Yamashita","year":"2003","journal-title":"Urology"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.lfs.2007.05.004","article-title":"Effects of doxazosin on blood flow and mRNA expression of nitric oxide synthase in the spontaneously hypertensive rat genitourinary tract","volume":"81","author":"M Yono","year":"2007","journal-title":"Life Sci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1038\/srep03822","article-title":"Prostatic ischemia induces ventral prostatic hyperplasia in the SHR; possible mechanism of development of BPH","volume":"4","author":"M Saito","year":"2014","journal-title":"Sci Rep"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/pros.22909","article-title":"Protective effect of tadalafil on the functional and structural changes of the rat ventral prostate caused by chronic pelvic ischemia","volume":"75","author":"M Zarifpour","year":"2015","journal-title":"Prostate"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1464-410X.2006.06448.x","article-title":"Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men","volume":"98","author":"K Kawabe","year":"2006","journal-title":"BJU Int"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1464-410X.2007.07339.x","article-title":"alpha-Blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms","volume":"101","author":"GM Pinggera","year":"2008","journal-title":"BJU Int"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1293\/tox.5.101","article-title":"Influence of terazosin on the epithelium of prostate gland of spontaneously hypertensive rats","volume":"5","author":"H Nakamura","year":"1992","journal-title":"J Toxicol Pathol"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","article-title":"Guidelines for reporting experiments involving animals: the ARRIVE guidelines","volume":"160","author":"JC McGrath","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"2 Pt 2","key":"ref21","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1111\/j.1464-410X.2011.10814.x","article-title":"Effect of silodosin on detrusor overactivity in the male spontaneously hypertensive rat","volume":"110","author":"S Inoue","year":"2012","journal-title":"BJU Int"},{"issue":"9","key":"ref22","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/iju.12501","article-title":"Lower urinary tract symptoms, benign prostatic hyperplasia\/benign prostatic enlargement and erectile dysfunction: are these conditions related to vascular dysfunction?","volume":"21","author":"S Shimizu","year":"2014","journal-title":"Int J Urol"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/j.clinthera.2009.11.024","article-title":"Silodosin: a selective alpha1A-adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia","volume":"31","author":"S Schilit","year":"2009","journal-title":"Clin Ther"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.juro.2013.03.110","article-title":"Effects of silodosin, a selective alpha1A-adrenoceptor antagonist, on bladder blood flow and bladder function in a rat model of atherosclerosis induced chronic bladder ischemia without bladder outlet obstruction","volume":"190","author":"Y Goi","year":"2013","journal-title":"J Urol"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/(SICI)1097-0045(19970215)30:3<202::AID-PROS9>3.0.CO;2-N","article-title":"Prostatic alpha 1-adrenoceptors and uroselectivity","volume":"30","author":"KE Andersson","year":"1997","journal-title":"Prostate"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1111\/j.1743-6109.2011.02416.x","article-title":"Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats","volume":"8","author":"A Morelli","year":"2011","journal-title":"J Sex Med"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00210-014-1040-y","article-title":"Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1alpha, and NF-kappaB","volume":"387","author":"RT Atawia","year":"2014","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.eururo.2006.12.011","article-title":"Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?","volume":"51","author":"G Kramer","year":"2007","journal-title":"Eur Urol"},{"issue":"9","key":"ref29","first-page":"2912","article-title":"Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling","volume":"8","author":"JA Tuxhorn","year":"2002","journal-title":"Clin Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.lfs.2014.12.006","article-title":"Cooperative effects of EGF, FGF, and TGF-beta1 in prostate stromal cells are different from responses to single growth factors","volume":"123","author":"M Hennenberg","year":"2015","journal-title":"Life Sci"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/pros.21138","article-title":"Antiproliferative and apoptotic effects of the herbal agent Pygeum africanum on cultured prostate stromal cells from patients with benign prostatic hyperplasia (BPH)","volume":"70","author":"MT Quiles","year":"2010","journal-title":"Prostate"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/S0022-5347(01)63162-8","article-title":"Induction of prostate apoptosis by doxazosin in benign prostatic hyperplasia","volume":"159","author":"N Kyprianou","year":"1998","journal-title":"J Urol"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/1097-0045(200101)46:1<45::AID-PROS1007>3.0.CO;2-U","article-title":"Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia","volume":"46","author":"DT Glassman","year":"2001","journal-title":"Prostate"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/S0022-5347(05)68873-8","article-title":"Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia","volume":"161","author":"JK Chon","year":"1999","journal-title":"J Urol"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3346\/jkms.2008.23.3.509","article-title":"Impacts of the quinazoline-based alpha1-antagonist, terazosin, and of the sulfonamide derivative, tamsulosin, on serum prostate-specific antigen and prostate volume","volume":"23","author":"JS Paick","year":"2008","journal-title":"J Korean Med Sci"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.pcan.4500849","article-title":"Three months\u2019 treatment with the alpha1-blocker alfuzosin does not affect total or transition zone volume of the prostate","volume":"9","author":"CG Roehrborn","year":"2006","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"25","key":"ref37","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"JD McConnell","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.eururo.2009.09.035","article-title":"The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study","volume":"57","author":"CG Roehrborn","year":"2010","journal-title":"Eur Urol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0133798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T19:19:39Z","timestamp":1718047179000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0133798"}},"subtitle":[],"editor":[{"given":"Aamir","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,26]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0133798","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,26]]}}}